BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37083755)

  • 1. Fibronectin on target cells attenuates natural cytotoxicity of NK cells via myeloid immune checkpoint ILT3/LILRB4/gp49B.
    Itagaki F; Nakatsuka K; Sakai H; Endo S; Su MT; Takai T
    Int Immunol; 2023 Jul; 35(7):339-348. PubMed ID: 37083755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-localization of Fibronectin Receptors LILRB4/gp49B and Integrin on Dendritic Cell Surface.
    Takahashi N; Itoi S; Su MT; Endo S; Takai T
    Tohoku J Exp Med; 2022 Jun; 257(3):171-180. PubMed ID: 35691913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid immune checkpoint ILT3/LILRB4/gp49B can co-tether fibronectin with integrin on macrophages.
    Itoi S; Takahashi N; Saito H; Miyata Y; Su MT; Kezuka D; Itagaki F; Endo S; Fujii H; Harigae H; Sakamoto Y; Takai T
    Int Immunol; 2022 Jul; 34(8):435-444. PubMed ID: 35689642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cells require immune checkpoint receptor LILRB4/gp49B to control neurotropic Zika virus infections in mice.
    Lee HN; Manangeeswaran M; Lewkowicz AP; Engel K; Chowdhury M; Garige M; Eckhaus MA; Sourbier C; Ireland DD; Verthelyi D
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 35132958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of checkpoint ILT3/LILRB4/gp49B binding to fibronectin ameliorates autoimmune disease in BXSB/Yaa mice.
    Su MT; Inui M; Wong YL; Takahashi M; Sugahara-Tobinai A; Ono K; Miyamoto S; Murakami K; Itoh-Nakadai A; Kezuka D; Itoi S; Endo S; Hirayasu K; Arase H; Takai T
    Int Immunol; 2021 Jul; 33(8):447-458. PubMed ID: 34089617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LILRB4/gp49B Co-Localizes with Integrin via Fibronectin at Focal Adhesion Sites on Mast Cells.
    Miyamoto S; Chiba T; Itoi S; Su MT; Takai T
    Tohoku J Exp Med; 2023 Mar; 259(4):273-284. PubMed ID: 36642505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs.
    Su MT; Kumata S; Endo S; Okada Y; Takai T
    Oncoimmunology; 2022; 11(1):2060907. PubMed ID: 35402083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin-LILRB4/gp49B interaction negatively regulates osteoclastogenesis through inhibition of RANKL-induced TRAF6/TAK1/NF-kB/MAPK signaling.
    Su MT; Ono K; Kezuka D; Miyamoto S; Mori Y; Takai T
    Int Immunol; 2023 Mar; 35(3):135-145. PubMed ID: 36331874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible expression of the gp49B inhibitory receptor on NK cells.
    Wang LL; Chu DT; Dokun AO; Yokoyama WM
    J Immunol; 2000 May; 164(10):5215-20. PubMed ID: 10799881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fibronectin-ILT3 Interaction Functions as a Stromal Checkpoint that Suppresses Myeloid Cells.
    Paavola KJ; Roda JM; Lin VY; Chen P; O'Hollaren KP; Ventura R; Crawley SC; Li B; Chen HH; Malmersjö S; Sharkov NA; Horner G; Guo W; Kutach AK; Mondal K; Zhang Z; Lichtman JS; Song C; Rivera LB; Liu W; Luo J; Wang Y; Solloway MJ; Allan BB; Kekatpure A; Starck SR; Haldankar R; Fan B; Chu C; Tang J; Molgora M; Colonna M; Kaplan DD; Hsu JY
    Cancer Immunol Res; 2021 Nov; 9(11):1283-1297. PubMed ID: 34426457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gp49B is a pathogenic marker for auto-antibody-producing plasma cells in lupus-prone BXSB/Yaa mice.
    Wong YL; Su MT; Sugahara-Tobinai A; Itoi S; Kezuka D; Endo S; Inui M; Takai T
    Int Immunol; 2019 May; 31(6):397-406. PubMed ID: 30768140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cells and mast cells from gp49B null mutant mice are functional.
    Rojo S; Stebbins CC; Peterson ME; Dombrowicz D; Wagtmann N; Long EO
    Mol Cell Biol; 2000 Oct; 20(19):7178-82. PubMed ID: 10982834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling via CD7 molecules on human NK cells. Induction of tyrosine phosphorylation and beta 1 integrin-mediated adhesion to fibronectin.
    Rabinowich H; Lin WC; Herberman RB; Whiteside TL
    J Immunol; 1994 Oct; 153(8):3504-13. PubMed ID: 7523496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rat orthologue to the inhibitory receptor gp49B is expressed by neutrophils and monocytes, but not by NK cells or mast cells.
    Bryceson YT; Torgersen KM; Inngjerdingen M; Berg SF; Hoelsbrekken SE; Fossum S; Dissen E
    Eur J Immunol; 2005 Apr; 35(4):1230-9. PubMed ID: 15756648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-linking of alpha 4 beta 1 and alpha 5 beta 1 fibronectin receptors enhances natural killer cell cytotoxic activity.
    Palmieri G; Serra A; De Maria R; Gismondi A; Milella M; Piccoli M; Frati L; Santoni A
    J Immunol; 1995 Dec; 155(11):5314-22. PubMed ID: 7594545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. gp49B-mediated negative regulation of antibody production by memory and marginal zone B cells.
    Fukao S; Haniuda K; Nojima T; Takai T; Kitamura D
    J Immunol; 2014 Jul; 193(2):635-44. PubMed ID: 24935931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of pathologic inflammation by leukocyte Ig-like receptor B4 and related inhibitory receptors.
    Katz HR
    Immunol Rev; 2007 Jun; 217():222-30. PubMed ID: 17498062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel regulatory role of gp49B on dendritic cells in T-cell priming.
    Kasai S; Inui M; Nakamura K; Kakizaki Y; Endo S; Nakamura A; Ito S; Takai T
    Eur J Immunol; 2008 Sep; 38(9):2426-37. PubMed ID: 18792399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of protein tyrosine phosphorylation by interaction of NK cells with fibronectin via alpha 4 beta 1 and alpha 5 beta 1.
    Gismondi A; Milella M; Palmieri G; Piccoli M; Frati L; Santoni A
    J Immunol; 1995 Apr; 154(7):3128-37. PubMed ID: 7534788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.